Welcome to LookChem.com Sign In|Join Free
  • or
1,2-Pyrrolidinedicarboxylic acid, 4-(4-chloro-3-fluorophenoxy)-, 1-(1,1-dimethylethyl) ester, (2S,4S)- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

869682-16-6

Post Buying Request

869682-16-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

869682-16-6 Usage

General Description

This chemical, also known as Suvorexant, is a prescription medication used to treat insomnia. It works by targeting orexin receptors in the brain, which are involved in regulating the sleep-wake cycle. Suvorexant is taken orally and is available in tablet form. It is usually taken once daily, before bedtime, and should not be taken with or immediately after a meal. Common side effects may include drowsiness, dizziness, and headache. It is important to follow the dosage and usage instructions provided by a healthcare professional when taking this medication.

Check Digit Verification of cas no

The CAS Registry Mumber 869682-16-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,9,6,8 and 2 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 869682-16:
(8*8)+(7*6)+(6*9)+(5*6)+(4*8)+(3*2)+(2*1)+(1*6)=236
236 % 10 = 6
So 869682-16-6 is a valid CAS Registry Number.

869682-16-6Upstream product

869682-16-6Downstream Products

869682-16-6Relevant academic research and scientific papers

NOVEL COMPOUNDS OF PROLINE AND MORPHOLINE DERIVATIVES

-

Page/Page column 68, (2008/06/13)

The present invention relates to compounds with the formulas (I), (II), and (III), or a pharmaceutically acceptable salt thereof: wherein T is a (4 to 10)-membered heterocyclyl selected from the group consisting of and wherein R1. R2 and R3 are as defined in the specification. The invention also relates to pharmaceutical compositions comprising the compounds of formulas (I), (II), and (III) and methods of treating a condition that is mediated by the modulation of the 11-β-hsd-1 enzyme, the method comprising administering to a mammal an effective amount of a compound of formulas (I), (II), and (III).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 869682-16-6